Seats are selling fast for our special screening of "A Table of Our Own", a groundbreaking documentary illuminating the untold stories, struggles, and triumphs of Black people in the psychedelics movement. Get tickets now https://bit.ly/3V3naLu
UC Berkeley Center for the Science of Psychedelics
@scipsychedelics.bsky.social
Exploring the potential of psychedelics for the betterment of all. @UC Berkeley
Last week in psychedelics on The Microdose: –Psilocybin has anti-inflammatory effects in Parkinson’s disease patients –Should 2 million veterans get psychedelic treatment? –5-MeO-DMT nasal spray shows promise for depression Read more: https://bit.ly/48eVsi1
Psilocybin has anti-inflammatory effects in Parkinson's disease patients; Should 2 million veterans get psychedelic treatment?
Plus: 5-MeO-DMT nasal spray shows promise for depression; And is the media overly positive about psilocybin?
bit.ly
In a convo with neuroscientist Christof Koch, @michaelpollan.bsky.social shared a thought-provoking metaphor: psychedelics “smudge the windshield” of everyday perception, forcing us to notice the invisible lens through which we experience the world. Watch at https://bit.ly/4zC37Co
BCSP Faculty Director Michael Silver speaks to a sold-out audience for the Big Brain Lecture Series on “What Psychedelics Reveal About How We See the World”
Two days of big questions, bold ideas, and new perspectives! From inspiring talks and live music to interactive workshops and a poster session, we explored the unknown together. Thanks to everyone who made the States of Consciousness conference last week unforgettable.
The visual cortex, plant intelligence, and the experience of becoming one with the universe ✨ If you missed the @michaelpollan.bsky.social and Christof Koch talk on psychedelics and consciousness last week, you can now watch it online: https://bit.ly/4zC37Co @ucberkeleyofficial.bsky.social
A Journey Into Consciousness: Michael Pollan and Christof Koch in Conversation - UC Berkeley Center for the Science of Psychedelics
Michael Pollan and neuroscientist Christof Koch explore the intersection of psychedelics and consciousness.
bit.ly
This week in psychedelics news: –Researchers go undercover to study Oregon’s psilocybin centers –Are psychedelic treatments leaving behind therapy? –Iowaska Church makes a deal with DEA Read in The Microdose: https://bit.ly/4dLs06d
Researchers go undercover to study Oregon's psilocybin centers; Are psychedelic treatments leaving behind therapy?
Plus: Iowaska Church makes a deal with DEA; Do music playlists in psilocybin trials rise and fall with participants' trips?
bit.ly
There are still a few tickets left to see @michaelpollan.bsky.social and neuroscientist Christof Koch tomorrow at Zellerbach Hall in Berkeley! Moderated by @shaylalove.bsky.social, together they’ll explore the intersection of consciousness and psychedelics. Get yours now: https://bit.ly/4x7o06U
Michael Pollan & Christof Koch: A Journey into Consciousness | Cal Performances
Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.
bit.ly
This week in pschedelics: FDA asks the public to weigh in on ibogaine clinical studies; Gabon wants its cut of the ibogaine boom Plus: The risks and benefits of five psychedelics; and Scholar argues for more religious perspectives in psychedelic studies Read more: https://bit.ly/4hUGPoo
FDA asks the public to weigh in on ibogaine clinical studies; Gabon wants its cut of the ibogaine boom
Plus: The risks and benefits of five psychedelics; and Scholar argues for more religious perspectives in psychedelic studies
themicrodose.substack.com
The deadline for the Mycoskie - UC Berkeley Psychedelic Documentary Fellowship has been extended until October 13, 2026. Learn more and apply at https://fellowships.journalism.berkeley.edu/mycoskie/
One more week! Grab your tickets to see A Journey into Consciousness, a conversation with @michaelpollan.bsky.social and neuroscientist Christof Koch on psychedelics and consciousness on Oct 13, 2026 at @ucberkeleyofficial.bsky.social. Tickets are going fast: https://bit.ly/4x7o06U
Michael Pollan & Christof Koch: A Journey into Consciousness | Cal Performances
Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.
bit.ly
What happens when GLP-1s mix with psychedelics? Neuroscientist Ali D. Güler discusses the emerging research on how GLP-1s affects the brain on The Microdose: https://bit.ly/4dkYvIe
What happens when GLP-1s mix with psychedelics? 5 Questions with neuroscientist Ali D. Güler
Güler discusses the emerging research on how GLP-1s affects the brain.
bit.ly
Join us for an evening with @michaelpollan.bsky.social and neuroscientist Christof Koch, co-presented with @calperformances.bsky.social. Moderated by @shaylalove.bsky.social, together they’ll explore the intersection of consciousness and psychedelics. Get your tickets now! https://bit.ly/4x7o06U
Michael Pollan & Christof Koch: A Journey into Consciousness | Cal Performances
Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.
bit.ly
What do octopuses on MDMA have to do with reopening critical periods? @neildegrassetyson.com sat down with BCSP Senior Science Advisor Gül Dölen on StarTalk to explore her research on the cutting edge of psychedelic science. Listen at https://bit.ly/4yoPoPk
This Is Your Brain on Psychedelics - StarTalk Special Edition
Could you reopen your childhood brain? Neil deGrasse Tyson, Chuck Nice, & Gary O'Reilly explore what a high octopus can teach us about the brain w/ Gül Dölen
bit.ly
BCSP Faculty Director Michael Silver will be giving a talk on "What Psychedelics Reveal About How We See the World" at The New Parkway Theater in Oakland on October 26 at 7pm in partnership with Big Brain Lectures. Get tickets now https://luma.com/mqef6lev
What Psychedelics Reveal About How We See the World · Luma
👁️ Is what you're seeing right now real, or a very convincing hallucination your brain is constructing? The camera is a common metaphor for human vision. In…
luma.com
What exactly is consciousness, and how can psychedelics help us study it? Join @michaelpollan.bsky.social and neuroscientist Christof Koch on Oct 13, 2026 in Berkeley for A Journey into Consciousness, moderated by @shaylalove.bsky.social. Get your tickets now! https://bit.ly/4x7o06U
Michael Pollan & Christof Koch: A Journey into Consciousness | Cal Performances
Author Michael Pollan returns for a discussion on the most intriguing questions at the intersection of psychedelics and consciousness.
bit.ly
Before a BCSP study participant takes a capsule of psilocybin, researchers must prepare in ways unlike almost anything else in basic science research. Learn more about what goes into conducting a psychedelics clinical trial. https://bit.ly/4rb2k8E
Inside a Psychedelics Clinical Trial - UC Berkeley Center for the Science of Psychedelics
Even for experienced researchers, working with psychedelics can pose new challenges, from procuring Schedule I substances to guiding participants through potential psychoactive effects to documenting ...
bit.ly
Science journalist @milesobrien.com talks to BCSP Senior Science Advisor Gül Dölen about her groundbreaking research on psychedelics' potential to reopen critical periods in the brain & unlock treatments for chronic pain. https://azpbs.org/resolvetosolve/2026/09/the-brain-the-pain-and-psychedelics/
The Brain, The Pain and Psychedelics
Could psychedelic therapy cure phantom limb pain? Amputee Miles O'Brien joins a trial testing if psychedelics can rewire the brain's pain circuits.
azpbs.org
Did psychedelics help build ancient civilizations? Journalist Andrew Lawler discusses new archeological tools for studying psychoactive plant residues with The Microdose: https://bit.ly/4jhkYtn
Did psychedelics help build ancient civilizations?: 5 Questions for journalist Andrew Lawler
Lawler discusses new archeological tools for studying psychoactive plant residues.
bit.ly
The latest in psychedelics news this week on The Microdose: – Definium trial suggests LSD could help treat anxiety – A new paper argues the need for more convincing placebos – Compass funds psilocybin-assisted therapist training Read now: https://bit.ly/4gWuYH6
Definium trial suggests LSD could help treat anxiety; “One patient meets God. The other gets itchy.”; and Compass funds psilocybin-assisted therapist training
Plus: New Mexico program licenses first producer, and an opinion on why taking the trip out of psychedelic medicine is a mistake
bit.ly
BCSP's Dr. Alia Lilienstein testified at the FDA hearing yesterday on the need for a standardized glossary when documenting adverse events in psychedelic clinical trials. Get an insider view on what it takes to conduct psychedelic research at https://bit.ly/4rb2k8E
The Microdose brings you the highlights from today’s four hour-long FDA hearing. https://themicrodose.substack.com/p/report-from-the-fdas-hearing-on-psychedelic
Report from the FDA’s hearing on psychedelic drugs
We’re bringing you the highlights from today’s four hour-long hearing, held by the U.S.
themicrodose.substack.com
The deadline for the Mycoskie - UC Berkeley Psychedelic Documentary Fellowship is October 5th! Learn more and apply at fellowships.journalism.berkeley.edu/mycoskie/
UC Berkeley Center for the Science of Psychedelics@scipsychedelics.bsky.social · 4mo ago🎥 The Mycoskie - UC Berkeley Psychedelic Documentary Fellowship is now accepting applications. 🗓️ Deadline: October 5, 2026 👉 Head to the link in our bio 🔗 or visit fellowships.journalism.berkeley.edu/mycoskie to submit your application.
Exciting news! Our research physician Dr. Alia Lilienstein has been selected to testify at today’s FDA public hearing on documenting adverse effects in psychedelics research. More on adverse effects and what it takes to run clinical research on psychedelics at https://bit.ly/4rb2k8E
This week in psychedelics: –A federal report encourages states to prepare for FDA approval of psychedelics –Could THC help with the psychedelic blinding problem? –Ketamine seized at the UK border hits record high Read the latest news in The Microdose: https://bit.ly/4qYfl5k
A federal report encourages states to prepare for FDA approval of psychedelics; Could THC help with the psychedelic blinding problem?
Plus: Ketamine seized at the UK border hits record high; an Arizona ibogaine trial; Study reveals cell signaling that differentiates hallucinogens and non-hallucinogens
bit.ly
Tickets on sale now! How can psychedelics research advance our understanding of consciousness? Join @michaelpollan.bsky.social and renowned neuroscientist Christof Koch in convo, moderated by @shaylalove.bsky.social. At Zellerbach Hall in Berkeley on Oct 13 at 7:30pm. 🎟️ ➡️ https://bit.ly/4x7o06U
We're hiring! The BCSP is seeking a Civic Science Fellow for a full-time, 18-month position focused on co-creating strong, inclusive connections between psychedelic science and the public. Apply now via @ucberkeleyofficial.bsky.social Careers! https://bit.ly/4652nZS
Drug historian David Herzberg discusses the history of “mind medicines” like Prozac and parallels between antidepressants and psychedelics on The Microdose this week. Read now: https://bit.ly/4cPQ4nW
Prozac Lessons: 5 Questions for drug historian David Herzberg
Herzberg discusses the history of “mind medicines” like Prozac and parallels between antidepressants and psychedelics.
bit.ly
How might Heidi Overton’s FDA Commissioner nomination shape psychedelics policy? And what is 4-OH-DiPT? Plus, pharmacists argue for a role in psychedelic therapy. Get the latest in psychedelics news on The Microdose: https://bit.ly/4qGvg8l
Ferriss-UC Berkeley Journalism fellow Michelle Lhooq was recently published in @newyorker.com. Our fellows report with complete editorial independence from the BCSP, and external news outlets select and fact-check their work. https://www.newyorker.com/news/the-lede/are-psychedelics-right-wing-now
Why the Right Wing Is Embracing This Psychedelic Drug
How the conservative activist Bryan Hubbard, with help from Rick Perry and Joe Rogan, persuaded Trump and the G.O.P. to embrace ibogaine, a psychedelic drug derived from an African shrub.
newyorker.com